Press release
Bullous Keratopathy Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Trefoil Therapeutics, Emmecell
Bullous Keratopathy Market
Download Sample Report to know more @ https://www.delveinsight.com/sample-request/bullous-keratopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Bullous Keratopathy Overview
The term keratopathy comes from the root words Kera, meaning cornea, and pathy, meaning disease; therefore, keratopathy is the disease of the cornea with a vast array of underlying causes and mechanisms. Keratopathy can occur due to an eye condition or systemic conditions. There are several types of keratopathy, including bullous keratopathy.
Bullous keratopathy is a pathological condition in which small vesicles, or bullae, formation occurs in the cornea due to endothelial dysfunction. Initially, there is endothelial trauma, followed by progressive stromal and epithelial edema. The epithelial edema results in the formation of bullae, hence the name bullous keratopathy.
Bullous keratopathy is also called pseudophakic bullous keratopathy (PBK) or pseudophakic corneal edema (PCE) in certain cases because it specifically occurs in individuals who have undergone cataract surgery and have had an intraocular lens (IOL) implanted in their eye. The main characterization is the formation of fluid-filled blisters or bullae on the cornea, which can cause pain, blurred vision, and other visual disturbances. This condition typically occurs due to damage to the corneal endothelium, the innermost layer of cells that maintains the cornea's clarity and controls its fluid balance.
There are several causes of bullous keratopathies, such as Fuchs' endothelial dystrophy, corneal surgery, and certain types of eye surgeries, eye trauma, cataract, glaucoma surgery, or corneal transplantation. Studies suggest prolonged contact lens wear can also damage the corneal endothelium and result in bullous keratopathy.
Click here to learn more @https://www.delveinsight.com/report-store/bullous-keratopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Bullous Keratopathy Market Report Key Highlights
Key Companies working in the Bullous Keratopathy market include Trefoil Therapeutics
Emmecell and many others.
Key Therapies involved in Bullous Keratopathy include TTHX1114 (NM141), EO2002, and many others.
Bullous Keratopathy Treatment Market
The treatment of bullous keratopathy aims to alleviate symptoms, improve visual function, and manage corneal edema. The treatment choice depends on the severity of the condition and the patient's circumstances. In the early stages, conservative therapies such as lubricating eye drops, hyperosmotic medicines, anti-glaucoma, steroids, ointments, or bandage contact lenses are used to reduce pain and protect the cornea. Furthermore, these also help draw out excess fluid from the cornea, reducing edema.
In severe cases, especially in cases where vision is significantly impaired, and quality of life is affected, corneal transplantation (keratoplasty) is considered. Different types of corneal transplantation, including full-thickness penetrating keratoplasty, anterior lamellar keratoplasty, descemet's stripping automated endothelial keratoplasty (DSAEK), or descemet's membrane endothelial keratoplasty (DMEK) are available. Aurion Biotech's VYZNOVA is the first approved allogeneic cell therapy for bullous keratopathy in Japan.
Learn more about the treatment market @https://www.delveinsight.com/report-store/bullous-keratopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Bullous Keratopathy Epidemiology Segmented by:
Bullous Keratopathy Incident Cases
Bullous Keratopathy treatment cases
Bullous Keratopathy prevalent cases
Bullous Keratopathy diagnosed cases
Bullous Keratopathy Drug Profile and Companies
Trefoil Therapeutics : TTHX1114 (NM141)
Emmecell : EO2002
And many others
Learn more about the Key Companies and Emerging Therapies @https://www.delveinsight.com/sample-request/bullous-keratopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Bullous Keratopathy Introduction
Executive Summary of Bullous Keratopathy
Disease Background and Overview
Epidemiology and patient population
Bullous Keratopathy Emerging Therapies
Bullous Keratopathy Market Outlook
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @https://www.delveinsight.com/sample-request/bullous-keratopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Bullous Keratopathy Pipeline Insight
https://www.delveinsight.com/report-store/neoantigen-based-personalized-cancer-therapeutic-vaccines-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Chronic Inducible Urticaria market Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bullous Keratopathy Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Trefoil Therapeutics, Emmecell here
News-ID: 3167598 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Bullous
Bullous Pemphigoid Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Bullous pemphigoid (BP) is a rare, chronic, autoimmune blistering skin disorder that primarily affects the elderly population. Characterized by large, fluid-filled blisters, intense itching, and significant discomfort, BP is associated with immune system dysfunction, where antibodies attack proteins in the skin.
Although rare, its prevalence is rising due to aging populations, improved diagnostic accuracy, and increasing autoimmune disease incidence worldwide.
The global bullous pemphigoid market is gaining momentum as awareness grows…
Bullous Pemphigoid Market Projected to Witness Innovation in Autoimmune Therapie …
Bullous Pemphigoid Market Snapshot
The Bullous Pemphigoid Market is projected to grow at a CAGR of 5.8% during the forecast period 2025-2032.
Coherent Market Insights proudly presents its latest Bullous Pemphigoid Market Research Report, delivering a detailed examination of the U.S. Bullous Pemphigoid Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration, and competitive strategies. As the…
Bullous Pemphigoid Treatment Market Size, Share, Analysis Report and Forecast 20 …
According to the report by Expert Market Research (EMR), the global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market. Aided by rising skin disease treatment market and rising accessibility of healthcare facilities, the skin disease treatment market is expected to grow at a CAGR of 3% in the forecast period of 2024-2032.
Bullous pemphigoid is a chronic autoimmune skin disorder characterised by large, tense blisters…
Bullous Keratopathy Treatment Market Size, Share, Industry, Forecast and Outlook …
Bullous Keratopathy Treatment Market Overview
The global Bullous Keratopathy Treatment Market is anticipated to achieve a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030.
Bullous Keratopathy
Bullous keratopathy, also known as corneal edema, is characterized by the swelling of the cornea due to the failure of the corneal endothelium to maintain its transparent and dehydrated state. This condition often results from corneal endothelial dystrophy or trauma. The…
Bullous Pemphigoid Market Size, Trends, Industry Statistics and Latest Insights …
Market Overview:
The bullous pemphigoid market reached a value of US$ 208.5 Million in 2022 and expects to reach US$ 1,252.7 Million by 2033, exhibiting a growth rate (CAGR) of 17.7% during 2023-2033.
The bullous pemphigoid market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the…
Bullous Pemphigoid Market 2020 Enhancement in Medical Sector
Bullous Pemphigoid - Pipeline Insight, 2020
The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Bullous Pemphigoid Market on the basis of stating current situation of the industry in 2020.
This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This…
